{"id":29816,"date":"2026-11-16T14:28:44","date_gmt":"2026-11-16T17:28:44","guid":{"rendered":"https:\/\/femama.org.br\/site\/?p=29816"},"modified":"2026-11-16T14:28:44","modified_gmt":"2026-11-16T17:28:44","slug":"consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/","title":{"rendered":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS"},"content":{"rendered":"<p><strong>Popula\u00e7\u00e3o tem at\u00e9 7 de dezembro para contribuir com a proposta de incorpora\u00e7\u00e3o do trastuzumabe deruxtecana ao rol de medicamentos ofertados pelo Sistema \u00danico de Sa\u00fade<\/strong><\/p>\n<p>Est\u00e1 aberta, a partir desta segunda-feira (16), a Consulta P\u00fablica n\u00ba 110\/2026, da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec), que avalia a inclus\u00e3o do <strong>trastuzumabe deruxtecana no SUS<\/strong> para pacientes adultos com c\u00e2ncer de mama HER2-positivo metast\u00e1tico ou que n\u00e3o pode ser removido por cirurgia, j\u00e1 tratados anteriormente com medicamentos direcionados \u00e0 prote\u00edna HER2.<\/p>\n<p>O trastuzumabe deruxtecana \u00e9 uma terapia inovadora que demonstrou benef\u00edcios importantes no controle da doen\u00e7a e na sobrevida das pacientes. Sua incorpora\u00e7\u00e3o ao SUS pode representar um avan\u00e7o no acesso a tratamentos mais eficazes, especialmente para mulheres que j\u00e1 passaram por outras terapias e precisam de novas alternativas.<\/p>\n<p>A recomenda\u00e7\u00e3o preliminar da Conitec foi desfavor\u00e1vel \u00e0 incorpora\u00e7\u00e3o, principalmente em raz\u00e3o dos custos do medicamento. Por isso, a participa\u00e7\u00e3o da sociedade nesta etapa \u00e9 fundamental para refor\u00e7ar a import\u00e2ncia do acesso \u00e0 inova\u00e7\u00e3o e contribuir para a reavalia\u00e7\u00e3o da proposta.<\/p>\n<p><strong>Como participar?<\/strong><\/p>\n<p><strong>At\u00e9<\/strong> <strong>7 de dezembro de 2026<\/strong>, pacientes, familiares, profissionais de sa\u00fade e demais interessados podem enviar suas contribui\u00e7\u00f5es pela plataforma Brasil Participativo, utilizando sua conta gov.br. Basta acessar o formul\u00e1rio no link abaixo, informar se concorda ou n\u00e3o com a incorpora\u00e7\u00e3o e justificar sua opini\u00e3o. Tamb\u00e9m \u00e9 poss\u00edvel compartilhar experi\u00eancias com o tratamento e apresentar informa\u00e7\u00f5es t\u00e9cnicas que possam contribuir para a decis\u00e3o.<\/p>\n<p><a href=\"https:\/\/brasilparticipativo.presidencia.gov.br\/processes\/consultas-publicas-conitec\/f\/6215\/\"><strong>Clique aqui para participar da Consulta P\u00fablica n\u00ba 110\/2026<\/strong><\/a><\/p>\n<p>Ap\u00f3s o encerramento da consulta, as contribui\u00e7\u00f5es ser\u00e3o analisadas pela Conitec, que emitir\u00e1 sua recomenda\u00e7\u00e3o final para subsidiar a decis\u00e3o do Minist\u00e9rio da Sa\u00fade. A FEMAMA refor\u00e7a a import\u00e2ncia da participa\u00e7\u00e3o social para ampliar o acesso a tratamentos oncol\u00f3gicos e promover mais equidade no cuidado \u00e0s pacientes do SUS.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Popula\u00e7\u00e3o tem at\u00e9 7 de dezembro para contribuir com a proposta de incorpora\u00e7\u00e3o do trastuzumabe deruxtecana ao rol de medicamentos ofertados pelo Sistema \u00danico de Sa\u00fade Est\u00e1 aberta, a partir desta segunda-feira (16), a Consulta P\u00fablica n\u00ba 110\/2026, da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec), que avalia a inclus\u00e3o [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":29819,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-29816","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"Popula\u00e7\u00e3o tem at\u00e9 7 de dezembro para contribuir com a proposta de incorpora\u00e7\u00e3o do trastuzumabe deruxtecana ao rol de medicamentos ofertados pelo Sistema \u00danico de Sa\u00fade Est\u00e1 aberta, a partir desta segunda-feira (16), a Consulta P\u00fablica n\u00ba 110\/2026, da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec), que avalia a inclus\u00e3o [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-16T17:28:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1140\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS\",\"datePublished\":\"2026-11-16T17:28:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento-1.png\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/\",\"name\":\"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento-1.png\",\"datePublished\":\"2026-11-16T17:28:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento-1.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento-1.png\",\"width\":1140,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/","og_locale":"pt_BR","og_type":"article","og_title":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA","og_description":"Popula\u00e7\u00e3o tem at\u00e9 7 de dezembro para contribuir com a proposta de incorpora\u00e7\u00e3o do trastuzumabe deruxtecana ao rol de medicamentos ofertados pelo Sistema \u00danico de Sa\u00fade Est\u00e1 aberta, a partir desta segunda-feira (16), a Consulta P\u00fablica n\u00ba 110\/2026, da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec), que avalia a inclus\u00e3o [&hellip;]","og_url":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2026-11-16T17:28:44+00:00","og_image":[{"width":1140,"height":500,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS","datePublished":"2026-11-16T17:28:44+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png","inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/","url":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/","name":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png","datePublished":"2026-11-16T17:28:44+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento-1.png","width":1140,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/consulta-publica-avalia-inclusao-de-novo-tratamento-para-cancer-de-mama-no-sus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Consulta p\u00fablica avalia inclus\u00e3o de novo tratamento para c\u00e2ncer de mama no SUS"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=29816"}],"version-history":[{"count":2,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29816\/revisions"}],"predecessor-version":[{"id":29818,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29816\/revisions\/29818"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/29819"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=29816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=29816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=29816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}